Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of Determining Endogenous Glucose Production in T1DM
NCT02028078Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Jan 2014
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Medical University of Graz. Primary endpoint: Tracer to Tracee Ratio (the absolute relative difference ARDi) at 8 hours. Started Jan 2014; status: completed.
Beyond the preview
Go deeper on NCT02028078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028078.